| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 205,780 | 375,241 | 340,059 | 224,732 |
| Short-term investments | 123,194 | 124,482 | 123,042 | 123,594 |
| Accounts receivable, net | 224,801 | 229,665 | 231,122 | 238,992 |
| Prepaid expenses | 12,866 | 12,606 | 8,942 | 10,424 |
| Income taxes receivable | 12,188 | 12,641 | 3,815 | 7,630 |
| Other current assets | 8,205 | 8,879 | 10,215 | 7,678 |
| Total current assets | 587,034 | 763,514 | 717,195 | 613,050 |
| Property and equipment, net | 41,094 | 39,180 | 38,636 | 38,944 |
| Goodwill | 1,268,248 | 1,260,732 | 1,255,423 | 1,242,606 |
| Gross carrying value | NaN | 74,698 | NaN | NaN |
| Accumulated amortization | NaN | 57,836 | NaN | NaN |
| Intangible assets, net | 15,937 | 16,862 | 14,802 | 9,296 |
| Operating and finance lease right-of-use assets | 36,871 | 34,330 | 35,702 | 38,690 |
| Deferred income tax assets | 65,708 | 73,922 | 79,758 | 88,729 |
| Other assets | 55,403 | 58,156 | 57,889 | 70,785 |
| Total assets | 2,070,295 | 2,246,696 | 2,199,405 | 2,102,100 |
| Accounts payable and accrued expenses | 236,930 | 419,530 | 352,233 | 303,360 |
| Current portion of debt and finance lease liabilities, net | 192,421 | 26,806 | 25,339 | 23,685 |
| Current portion of operating lease liabilities | 11,885 | 11,591 | 12,226 | 12,049 |
| Income taxes payable | 1,402 | 984 | 2,749 | 1,949 |
| Total current liabilities | 442,638 | 458,911 | 392,547 | 341,043 |
| Long-term debt and finance lease liabilities, net | 398,348 | 570,532 | 577,169 | 583,863 |
| Long-term operating lease liabilities | 27,061 | 25,686 | 27,533 | 29,963 |
| Long-term professional liabilities | 236,949 | 238,353 | 239,679 | 244,162 |
| Deferred income tax liabilities | 57,002 | 57,024 | 38,285 | 36,019 |
| Other liabilities | 29,721 | 30,336 | 33,526 | 33,297 |
| Total liabilities | 1,191,719 | 1,380,842 | 1,308,739 | 1,268,347 |
| Preferred stock .01 par value 1,000,000 shares authorized none issued | 0 | 0 | 0 | 0 |
| Common stock .01 par value 200,000,000 shares authorized 82,061,119 and 82,976,110 shares issued and outstanding, respectively | 821 | 830 | 858 | 869 |
| Additional paid-in capital | 931,258 | 947,566 | 1,006,197 | 1,021,290 |
| Accumulated other comprehensive income | 77 | 610 | 446 | 137 |
| Retained deficit | -53,580 | -83,152 | -116,835 | -188,543 |
| Total shareholders' equity | 878,576 | 865,854 | 890,666 | 833,753 |
| Total liabilities and shareholders' equity | 2,070,295 | 2,246,696 | 2,199,405 | 2,102,100 |
Pediatrix Medical Group, Inc. (MD)
Pediatrix Medical Group, Inc. (MD)